<?xml version="1.0"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2014//EN" "http://www.ncbi.nlm.nih.gov/corehtml/query/DTD/pubmed_140101.dtd">
<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32775985</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>09</Month>
            <Day>28</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">2590-0595</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <MedlineDate>2020 Jul-Aug</MedlineDate>
                    </PubDate>
                </JournalIssue>
                <Title>Kidney medicine</Title>
                <ISOAbbreviation>Kidney Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Vitamin D Analogues and Coronary Calcification in CKD Stages 3 and 4: A Randomized Controlled Trial of Calcitriol Versus Paricalcitol.</ArticleTitle>
            <Pagination>
                <MedlinePgn>450-458</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.xkme.2020.05.009</ELocationID>
            <Abstract>
                <AbstractText Label="Rationale &amp; Objective" NlmCategory="UNASSIGNED">Mineral and bone disorder in chronic kidney disease (CKD) is associated with progression of coronary artery calcification (CAC). Mineral and bone disorder often is treated with calcitriol and other vitamin D receptor activators, including paricalcitol, agents that may have differential effects on calcium, phosphate, and parathyroid hormone levels. Accordingly, we investigated whether these agents have differential effects on CAC progression in patients with CKD.</AbstractText>
                <AbstractText Label="Study Design" NlmCategory="UNASSIGNED">Randomized, double-concealed, 48-week clinical trial.</AbstractText>
                <AbstractText Label="Setting &amp; Participants" NlmCategory="UNASSIGNED">CKD stage 3 or 4 with secondary hyperparathyroidism with CAC scoreÂ &gt;Â 0 and no prior treatment with activated vitamin D.</AbstractText>
                <AbstractText Label="Intervention" NlmCategory="UNASSIGNED">Calcitriol versus paricalcitol.</AbstractText>
                <AbstractText Label="Outcomes" NlmCategory="UNASSIGNED">The primary outcome was log-transformed CAC change. Secondary outcomes included percent change in CAC volume, valvular calcifications, and bone mineral metabolism markers.</AbstractText>
                <AbstractText Label="Results" NlmCategory="UNASSIGNED">Among 44 individuals randomly assigned, mean age was 65 years and mean estimated glomerular filtration rate was 27Â mL/min/1.73Â m<sup>2</sup>. Median CAC score was 140 (IQR, 55-277) Agatston units at baseline. There was no significant difference in CAC progression between treatment arms (<i>P</i>Â =Â 0.06). After adjustment for baseline CAC score (log), treatment group remains nonsignificant (<i>P</i>Â =Â 0.08). Further adjustment for creatinine level and/or CKD stage did not change the association. In secondary analyses adjusting for dose level of activated vitamin D, treatment group was significant (<i>P</i>Â =Â 0.01), and when dose level was also included in the model, the coefficient for individuals in the paricalcitol group was significantly associated with CAC progression (<i>P</i>Â =Â 0.02). An interaction term between dosing level and CKD stage was significant at the highest dosing level (<i>P</i>Â =Â 0.04).</AbstractText>
                <AbstractText Label="Limitations" NlmCategory="UNASSIGNED">Pilot single-center study.</AbstractText>
                <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">In patients with CKD with secondary hyperparathyroidism naive to activated vitamin D therapy, there was no difference in CAC or valvular progression in participants receiving calcitriol compared with paricalcitol during a 48-week period.</AbstractText>
                <AbstractText Label="Funding" NlmCategory="UNASSIGNED">Abbvie, Inc.</AbstractText>
                <AbstractText Label="Trial Registration" NlmCategory="UNASSIGNED">NCT00752102.</AbstractText>
                <CopyrightInformation>Â© 2020 The Authors.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Anis</LastName>
                    <ForeName>Karim H</ForeName>
                    <Initials>KH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Joslin Diabetes Center, Harvard Medical School, Boston, MA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pober</LastName>
                    <ForeName>David</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Joslin Diabetes Center, Harvard Medical School, Boston, MA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rosas</LastName>
                    <ForeName>Sylvia E</ForeName>
                    <Initials>SE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Joslin Diabetes Center, Harvard Medical School, Boston, MA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <DataBankList CompleteYN="Y">
                <DataBank>
                    <DataBankName>ClinicalTrials.gov</DataBankName>
                    <AccessionNumberList>
                        <AccessionNumber>NCT00752102</AccessionNumber>
                    </AccessionNumberList>
                </DataBank>
            </DataBankList>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>UL1 TR001878</GrantID>
                    <Acronym>TR</Acronym>
                    <Agency>NCATS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Kidney Med</MedlineTA>
            <NlmUniqueID>101756300</NlmUniqueID>
            <ISSNLinking>2590-0595</ISSNLinking>
        </MedlineJournalInfo>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="CommentIn">
                <RefSource>Kidney Med. 2020 Jul 02;2(4):385-387</RefSource>
                <PMID Version="1">32779642</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Vascular calcification</Keyword>
            <Keyword MajorTopicYN="N">activated vitamin D</Keyword>
            <Keyword MajorTopicYN="N">calcitriol</Keyword>
            <Keyword MajorTopicYN="N">chronic kidney disease</Keyword>
            <Keyword MajorTopicYN="N">coronary calcification</Keyword>
            <Keyword MajorTopicYN="N">paricalcitol</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32775985</ArticleId>
            <ArticleId IdType="doi">10.1016/j.xkme.2020.05.009</ArticleId>
            <ArticleId IdType="pii">S2590-0595(20)30113-8</ArticleId>
            <ArticleId IdType="pmc">PMC7406841</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Nephrol. 2010;31(2):165-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20016142</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Heart Valve Dis. 2009 Jul;18(4):429-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19852148</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1620-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24970869</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Nephrol. 2017 May 6;6(3):100-110</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28540199</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Lab Clin Med. 2002 May;139(5):279-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12032488</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Kidney Dis. 2011 Oct;58(4):519-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21783289</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int Suppl. 2009 Aug;(113):S1-130</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19644521</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Bone Miner Res. 2006 Mar;21(3):484-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16491297</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Nephrol. 2015 Dec;19(6):1090-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25757535</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Soc Nephrol. 2005 Feb;16(2):507-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15601745</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Kidney Dis. 1995 Nov;26(5):852-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7485144</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 2005 Sep;68(3):1258-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16105059</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Kidney Dis. 2003 Oct;42(4 Suppl 3):S1-201</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14520607</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Atherosclerosis. 2018 Apr;271:53-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29459266</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Cardiol. 2012 Dec 15;110(12):1735-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22980963</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 2007 Sep;72(6):709-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17597697</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):16810-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17942703</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2012 Feb 15;307(7):674-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22337679</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Kidney Dis. 1998 Nov;32(5 Suppl 3):S142-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9820472</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Coll Cardiol. 1990 Mar 15;15(4):827-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2407762</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephrol Dial Transplant. 2005 Jul;20(7):1370-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15855208</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephrol Dial Transplant. 2006 Jul;21(7):1906-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16554325</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2003 Jul 31;349(5):446-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12890843</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Nephrol. 2007;27(1):36-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17215573</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 2009 Nov;76(9):991-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19692998</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Cardiol. 2017 Jun 1;2(6):635-643</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28329057</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AJR Am J Roentgenol. 2004 May;182(5):1327-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15100140</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Soc Nephrol. 2015 Feb;26(2):439-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25145930</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Kidney Dis. 2004 Dec;44(6):1024-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15558523</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Soc Nephrol. 1999 May;10(5):980-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10232683</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>